IART – Integra LifeSciences Holdings Corporation
IART — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
12.54
Margin Of Safety %
Put/Call OI Ratio
0.38
EPS Next Q Diff
-0.31
EPS Last/This Y
9.08
EPS This/Next Y
0.22
Price
9.34
Target Price
15.83
Analyst Recom
3
Performance Q
-25.72
Upside
-1,686.9%
Beta
1.05
Ticker: IART
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | IART | 9.58 | 0.59 | 0.00 | 1074 |
| 2026-03-10 | IART | 9.52 | 0.59 | 0.00 | 1075 |
| 2026-03-11 | IART | 9.61 | 0.59 | 0.00 | 1076 |
| 2026-03-12 | IART | 9.2 | 0.59 | 6.50 | 1079 |
| 2026-03-13 | IART | 9.17 | 0.59 | 6.50 | 1079 |
| 2026-03-17 | IART | 9.09 | 0.62 | 999.99 | 1096 |
| 2026-03-18 | IART | 8.9 | 0.62 | 999.99 | 1096 |
| 2026-03-19 | IART | 8.9 | 0.44 | 999.99 | 976 |
| 2026-03-20 | IART | 8.94 | 0.34 | 0.00 | 907 |
| 2026-03-23 | IART | 9.43 | 0.36 | 0.00 | 574 |
| 2026-03-24 | IART | 9.53 | 0.35 | 0.33 | 586 |
| 2026-03-25 | IART | 9.57 | 0.35 | 0.00 | 590 |
| 2026-03-26 | IART | 9.38 | 0.37 | 999.99 | 570 |
| 2026-03-27 | IART | 9.21 | 0.37 | 999.99 | 570 |
| 2026-03-30 | IART | 9.1 | 0.38 | 0.00 | 575 |
| 2026-03-31 | IART | 9.43 | 0.38 | 0.00 | 575 |
| 2026-04-01 | IART | 9.56 | 0.38 | 0.00 | 577 |
| 2026-04-02 | IART | 9.53 | 0.38 | 0.00 | 577 |
| 2026-04-06 | IART | 9.31 | 0.38 | 999.99 | 580 |
| 2026-04-07 | IART | 9.34 | 0.38 | 999.99 | 580 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | IART | 9.57 | -1.4 | - | 2.34 |
| 2026-03-10 | IART | 9.52 | -1.4 | - | 2.34 |
| 2026-03-11 | IART | 9.61 | -1.4 | - | 2.34 |
| 2026-03-12 | IART | 9.19 | -1.4 | - | 2.34 |
| 2026-03-13 | IART | 9.24 | -1.4 | - | 2.34 |
| 2026-03-17 | IART | 9.08 | -1.4 | - | 2.34 |
| 2026-03-18 | IART | 8.89 | -1.4 | - | 2.34 |
| 2026-03-19 | IART | 8.90 | -1.4 | - | 2.34 |
| 2026-03-20 | IART | 8.94 | -1.4 | - | 2.34 |
| 2026-03-23 | IART | 9.43 | -1.4 | - | 2.34 |
| 2026-03-24 | IART | 9.55 | -1.4 | - | 2.34 |
| 2026-03-25 | IART | 9.56 | -1.4 | - | 2.34 |
| 2026-03-26 | IART | 9.38 | -1.4 | - | 2.34 |
| 2026-03-27 | IART | 9.21 | -1.4 | - | 2.34 |
| 2026-03-30 | IART | 9.10 | -1.4 | - | 2.34 |
| 2026-03-31 | IART | 9.42 | -1.4 | - | 2.34 |
| 2026-04-01 | IART | 9.56 | -1.4 | - | 2.34 |
| 2026-04-02 | IART | 9.53 | -1.4 | - | 2.34 |
| 2026-04-06 | IART | 9.30 | -1.4 | - | 2.34 |
| 2026-04-07 | IART | 9.34 | -1.4 | - | 2.34 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | IART | 0.08 | 2.55 | 11.38 |
| 2026-03-10 | IART | 0.08 | 2.55 | 11.38 |
| 2026-03-11 | IART | 0.08 | 2.55 | 11.21 |
| 2026-03-12 | IART | 0.08 | 2.55 | 11.21 |
| 2026-03-13 | IART | 0.08 | 2.55 | 11.21 |
| 2026-03-17 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-18 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-19 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-20 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-23 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-24 | IART | 0.08 | 2.72 | 11.21 |
| 2026-03-25 | IART | 0.08 | 2.72 | 12.54 |
| 2026-03-26 | IART | 0.08 | 2.72 | 12.54 |
| 2026-03-27 | IART | 0.08 | 2.72 | 12.54 |
| 2026-03-30 | IART | 0.08 | 2.72 | 12.54 |
| 2026-03-31 | IART | 0.08 | 2.72 | 12.54 |
| 2026-04-01 | IART | 0.08 | 2.72 | 12.54 |
| 2026-04-02 | IART | 0.08 | 2.72 | 12.54 |
| 2026-04-06 | IART | 0.08 | 2.72 | 12.54 |
| 2026-04-07 | IART | 0.08 | 2.72 | 12.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.83
Avg. EPS Est. Current Quarter
0.4
Avg. EPS Est. Next Quarter
0.52
Insider Transactions
0.08
Institutional Transactions
2.72
Beta
1.05
Average Sales Estimate Current Quarter
383
Average Sales Estimate Next Quarter
425
Fair Value
Quality Score
38
Growth Score
34
Sentiment Score
17
Actual DrawDown %
87.9
Max Drawdown 5-Year %
-88.4
Target Price
15.83
P/E
Forward P/E
3.64
PEG
0.53
P/S
0.44
P/B
0.7
P/Free Cash Flow
EPS
-6.73
Average EPS Est. Cur. Y
2.34
EPS Next Y. (Est.)
2.56
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-31.58
Relative Volume
1.06
Return on Equity vs Sector %
-77
Return on Equity vs Industry %
-61.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
◆
IART
Healthcare
$9.33
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
41.4
Range 1M
49.6%
Sup Dist
1.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
5.4%
EPS NY
9.1%
52W%
5.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+379.6% upside
Upside
+379.6%
Quality
38
Integra LifeSciences Holdings CSector: Healthcare
Industry: Medical Devices
Employees: 4427
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
IART
Latest News
—
Caricamento notizie per IART…
stock quote shares IART – Integra LifeSciences Holdings Corporation Stock Price stock today
news today IART – Integra LifeSciences Holdings Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch IART – Integra LifeSciences Holdings Corporation yahoo finance google finance
stock history IART – Integra LifeSciences Holdings Corporation invest stock market
stock prices IART premarket after hours
ticker IART fair value insiders trading